Diagnosing the Cause of RPLEstablishing the correct diagnosis is the first step in determining effective treatment for couples with recurrent pregnancy loss. RPL results from a problem within the pregnancy itself or within the uterine environment where the pregnancy implants and grows. Diagnostic tests useful in identifying individuals at greater risk for a problem within the pregnancy itself include:
- Chromosome analysis done on both prospective parents
- Chromosome analysis results from previous pregnancy losses and from both parents
- Ultrasound examination of the uterine cavity after sterile water is injected or hysterosonography (saline ultrasound, sonohysterogram, fluid ultrasound, ultrasound)
- Dye X-ray test of the uterus and fallopian tubes or hysterosalpingography
- Hysteroscopic evaluation of the uterine cavity
- Evaluation of hormonal response of the uterine lining
- Immunologic testing useful in the diagnosis and management of recurrent pregnancy loss in affected couples. Such tests include: a)Antiphospholipid antibody (APA) panel; b) antinuclear antibody (ANA) panel; c)Antithyroid antibody panel (i.e. antithyroglobulin and antimicrosomal antibodies); d) Reproductive immunophenotype; e) Natural killer cell activity (NKa) using the the K562 target cell test.
- Alloimmune testing of both the male and female partners (DQ alpha and HLA)
- Thrombophila Panel